We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
AUM
$3.36B
AUM Growth
+$82M
Cap. Flow
+$65.6M
Cap. Flow %
1.95%
Top 10 Hldgs %
33.03%
Holding
318
New
25
Increased
113
Reduced
72
Closed
11

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$22.7M
2
BURL icon
Burlington
BURL
+$14.9M
3
PRCT icon
Procept Biorobotics
PRCT
+$13.9M
4
DELL icon
Dell
DELL
+$10.2M
5
ASML icon
ASML
ASML
+$7.37M

Top Sells

Rank Stock Value
1
DV icon
DoubleVerify
DV
+$45.6M
2
PGR icon
Progressive
PGR
+$16.3M
3
TDC icon
Teradata
TDC
+$14.4M
4
NFLX icon
Netflix
NFLX
+$13.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$7.45M

Sector Composition

Rank Sector Weight
1 Technology 31.04%
2 Healthcare 18.24%
3 Communication Services 14.1%
4 Financials 12.02%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
101
GE Aerospace
GE
$374B
$2.96M 0.09%
18,639
-5,168
-22% -$825K
ORLY icon
102
O'Reilly Automotive
ORLY
$72.9B
$2.93M 0.09%
41,625
-150
-0.4% -$10.4K
AXP icon
103
American Express
AXP
$227B
$2.91M 0.09%
12,579
+1,300
+12% +$301K
RMD icon
104
ResMed
RMD
$30.6B
$2.81M 0.08%
14,700
+12,500
+568% +$2.54M
VUG icon
105
Vanguard Morningstar Growth ETF
VUG
$220B
$2.79M 0.08%
44,724
UNP icon
106
Union Pacific
UNP
$174B
$2.75M 0.08%
12,174
-382
-3% -$89.5K
XYZ
107
Block Inc
XYZ
$48.4B
$2.6M 0.08%
40,310
-835
-2% -$58.4K
AJG icon
108
Arthur J. Gallagher & Co
AJG
$64.1B
$2.5M 0.07%
9,657
-139
-1% -$34.5K
EMR icon
109
Emerson Electric
EMR
$83.9B
$2.49M 0.07%
22,648
CRWD icon
110
CrowdStrike
CRWD
$194B
$2.34M 0.07%
24,472
+1,456
+6% +$121K
BN icon
111
Brookfield
BN
$104B
$2.34M 0.07%
+84,545
New +$2.36M
MU icon
112
Micron Technology
MU
$930B
$2.31M 0.07%
17,583
HON icon
113
Honeywell
HON
$77B
$2.2M 0.07%
10,915
+184
+2% +$35K
HUBB icon
114
Hubbell
HUBB
$25B
$2.13M 0.06%
5,836
-82
-1% -$32.2K
ECL icon
115
Ecolab
ECL
$78.1B
$2.12M 0.06%
8,913
PFE icon
116
Pfizer
PFE
$143B
$2.1M 0.06%
75,197
+2,575
+4% +$70.9K
PLTR icon
117
Palantir
PLTR
$295B
$2.04M 0.06%
80,650
+13,134
+19% +$296K
WMT icon
118
Walmart Inc
WMT
$885B
$2.02M 0.06%
29,787
+2,172
+8% +$137K
LRCX icon
119
Lam Research
LRCX
$367B
$1.98M 0.06%
18,560
-320
-2% -$30.7K
CCSI icon
120
Consensus Cloud Solutions
CCSI
$670M
$1.93M 0.06%
112,537
+4,824
+4% +$78.1K
ADP icon
121
Automatic Data Processing
ADP
$106B
$1.84M 0.05%
7,726
BRK.A icon
122
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.84M 0.05%
3
ARM icon
123
Arm
ARM
$256B
$1.74M 0.05%
10,612
+4,855
+84% +$604K
CSCO icon
124
Cisco
CSCO
$457B
$1.72M 0.05%
36,247
-800
-2% -$38K
TXN icon
125
Texas Instruments
TXN
$252B
$1.64M 0.05%
8,432
-2,037
-19% -$376K

Similar funds

Chicago Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Chicago Capital held 318 positions worth $3.36B, up 2.5% from $3.28B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Chicago Capital's Q2 2024 filing shows 25 new, 113 increased, 72 reduced and 11 closed positions. Its largest new stake was Procept Biorobotics: 232,983 shares worth $14.2M. The largest sale was DoubleVerify, an estimated $45.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Chicago Capital's largest Q2 2024 buy was Procept Biorobotics: 232,983 shares worth $14.2M.
  • Chicago Capital added most to Ligand Pharmaceuticals in Q2 2024, an estimated $22.7M increase.
  • Chicago Capital's biggest Q2 2024 reduction was DoubleVerify, cutting an estimated $45.6M.
  • Chicago Capital fully exited lululemon athletica in Q2 2024, selling an estimated $4.4M.
  • Chicago Capital's ten largest holdings make up 33% of its $3.36B portfolio in Q2 2024.
  • Chicago Capital opened 25 new positions and closed 11 in Q2 2024.
  • Chicago Capital's portfolio value rose 2.5% quarter-over-quarter to $3.36B.

Based on Chicago Capital's 13F filing for Q2 2024, filed 6 Aug 2024.